These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2005-001481-14 LOCAL-TAX Trial: Local intracoronary administration of Paclitaxel after stent implantation for prevention of restenosis in comparison with stent implantation alone and with implantation of a Paclitaxe... 2008-10-08 due-trials
Reported results 2005-003305-90 A Randomized Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD after Unrelated Donor G-CSF mobilized Peripheral Blood Mononuclear Cell (G-PBMC)... 2014-12-31 due-trials
Reported results Terminated 2005-004540-31 Monozentrische, randomisierte, placebo-kontrollierte Studie zur Evaluation der Nephroprotektion durch Theophyllin unter Cisplatin-haltiger Chemotherapie 2009-12-15 due-trials
Exempt 2005-005678-61 Entwicklung einer Untersuchungsmethode zur Bestimmung des NO-Transferfaktors der Lunge Evaluierung der Methode und Normwerterhebung an gesunden Probanden (Development of a new method for steady-state ... not-yet-due
Reported results 2006-003816-23 Multicenter phase II study with pemetrexed in patients with pre-treated metastatic soft tissue sarcomas 2009-12-15 due-trials
Reported results Terminated 2007-000353-65 Weight gain, eating patterns and development of body composition during initiation of basal insulin therapy: a comparison of insulin determir and insulin glargine 2012-10-18 due-trials
Reported results Terminated 2007-000775-42 Effects of Rimonabant on Liver Fat, Visceral Adipose Tissue Mass and early Markers of CardioDiabetes in obese Subjects with the Metabolic Syndrome – a randomized, double-blind clinical trial 2008-12-15 due-trials
Not reported 2007-001478-10 CWS-2007-HR: A randomised phase-III trial of the Cooperative Weichteilsarkom Studiengruppe for localised high-risk Rhabdomyosarcoma and localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in children,... 2022-06-30 due-trials
Ongoing 2007-003858-29 Prospektive multizentrische Phase-III-Studie zur ambulanten Therapie mit Capecitabin versus Cisplatin plus Capecitabin beim fortgeschrittenen Adenokarzinom der Gallenblase und Gallenwege („CISCA-Studi... not-yet-due
Reported results 2007-003986-42 Prospective, randomised, placebo controlled, double blind monocenter trial for the prophylactic treatment of diarrhoea with rifaximin for travellers to South- and Southeast-Asia 2012-09-21 due-trials
Reported results 2007-004941-13 Serumspiegel von intravenös und enteral appliziertem Moxifloxacin bei kritisch kranken Intensivpatienten 2012-12-31 due-trials
Reported results 2007-005063-96 Prospective trial of intravenous levetiracetam in patients with primary brain tumors and at least one symptomatic seizure who undergo biopsy or cytoreductive surgery. 2009-08-19 due-trials
Reported results Terminated 2007-006016-33 Multicenter Phase II study of haploidentical hematopoietic cell transplantation with CD3/CD19 depleted grafts after a reduced intensity conditioning regimen for adult patients with acute leukemia 2015-12-30 due-trials
Reported results 2009-012203-26 Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia 2016-07-31 due-trials
Reported results 2010-019033-98 A phase II study to evaluate safety and efficacy of combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma 2015-06-23 due-trials
Not reported 2010-021576-28 Effects of transfusion thresholds on neurocognitive outcome of extremely low birth weight infants (ETTNO) a blinded randomized controlled multicenter trial 2015-11-18 due-trials
Reported results Terminated 2010-022103-21 Neoadjuvant treatment of locoregional metastases in malignant melanoma (AJCC stage IIIB/C) with Multiferon: a phase IIa DeCOG trial 2013-03-31 due-trials
Not reported 2010-024152-29 Canakinumab for Behçet`s Disease Resistant to Standard Treatment (CanBeDisT) 2014-07-14 due-trials
Ongoing 2011-000659-18 Treatment of therapy resistant Alopecia areata with fumaric acid esters (Fumaderm® and Fumaderm initial®) – an open, single center, non-randomized, pilot study with 40 patients not-yet-due
Reported results 2011-002192-41 Multicenter phase II study of peritransplantation immunosuppression using ATG, rituximab, sirolimus and mycophenolate mofetil in patient receiving mismatched hematopoietic cell transplantation after r... 2016-08-17 due-trials
Completed, report not yet due 2011-002434-40 Highdose Chemotherapy and transplantation of 34+ selected stem cell for progressive systemic sclerosis Modification according to manifestation Hochdosis-Chemotherapie und autologe Retransfusion C... 2023-09-27 not-yet-due
Reported results Terminated 2011-002920-41 Open-label Trial of Stelara® (Ustekinumab) In Patients with Pyoderma gangrenosum – an open, non-placebo controlled pilot study with 10 patients. 2014-01-17 due-trials
Reported results Terminated 2011-004405-25 Study for prevention of peritoneal carcinomatosis in patients with stomach cancer Studie zur Verhinderung der Peritonealkarzinose beim Magenkarzinom 2015-06-09 due-trials
Reported results 2012-005617-39 Pharmacokinetics of Tigecycline in Patients Receiving Continuous Renal Replacement Therapy 2018-08-20 due-trials
Reported results Terminated 2013-001546-34 Neoadjuvant treatment with the combination of vemurafenib and cobimetinib (GDC-0973) in limited metastasis of malignant melanoma (AJCC stage IIIC/IV) and integrated biomarker study: a single armed ph... 2020-05-14 due-trials
Not reported 2013-003306-45 An open-label, uncontrolled, single arm phase II trial of BKM120 (Buparlisib) in patients with metastatic melanoma with brain metastases not eligible for surgery or radiosurgery Offene unverblin... 2018-07-31 due-trials
Reported results 2013-003678-29 Phase II multicenter, open‐label, single arm clinical Study of Pomalidomide and dexamethasonE in RelapSed myeloma Plus rEsponse adapted Cyclophosphamide as a Tailored InnoVativE strategy Eine multi... 2017-08-01 due-trials
Exempt 2014-001874-32 Safety and efficacy of a bilateral single subretinal injection of rAAV.hCNGA3 in adult and minor patients with CNGA3-linked achromatopsia investigated in a randomized, wait list controlled, observer-m... not-yet-due
Exempt 2014-003561-15 Safety and Tolerance of Immunomodulating Therapy with Donor-specific Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation Sicherheit und Verträglichkeit der Anwendung von Mesench... not-yet-due
Reported results Terminated 2014-003581-25 Anti-inflammatory pulmonal therapy of CF-patients with Amitriptyline and Placebo - Randomised, double-blind, placebo-controlled cohort trial 2019-09-30 due-trials
Reported results Terminated 2014-005004-21 THOR - Tübingen Choroideremia gene therapy trial open label Phase 2 clinical trial using an adeno-associated viral vector (AAV2) encoding Rab-escort protein 1 (REP1) THOR – Tübingen Choroideremie, ... 2018-02-26 due-trials
Reported results Terminated 2014-005109-19 Apixaban for treatment of embolic stroke of undetermined source Apixaban zur Behandlung von embolischen Schlaganfall unbestimmter Quelle 2021-11-09 due-trials
Reported results 2015-000125-36 Daptomycin concentration in drainage fluid and blood samples of ICU patients Konzentration von Daptomycin im Blut und in der Wundflüssigkeit bei kritisch kranken Patienten der anästhesiologischen I... 2019-03-31 due-trials
Reported results 2015-000978-35 Statin Treatment of Oxysterol Pathology in SPG5: a Randomized Controlled Trial -Proof of Principle Therapie der Oxysterol-Pathologie bei Patienten mit SPG5: Eine randomisierte kontrollierte Stdie ... 2016-03-01 due-trials
Reported results 2015-002288-41 Open-label pilot Phase I / II study on hyperthermic intraperitoneal chemotherapy ( HIPEC ) after macroscopically complete resection ( R0 / R1 ) of adenocarcinomas of the pancreas ( PanHIPEC ) Open-... 2018-10-18 due-trials
Reported results Terminated 2015-003171-29 The correlation between vancomycin AUC and trough levels during intermittent dosing of vancomycin and plateau levels during continuous infusion - Pharmacokinetic evaluation of Vancomycin and the influ... 2016-12-12 due-trials
Ongoing 2015-005281-29 Prospective phase I/II study: Patient-individualized peptide vaccination based on whole exome sequencing with adjuvant GM-CSF in children with relapsed acute lymphoblastic leukemia not-yet-due
Reported results Terminated 2015-005740-34 Effectiveness of Dapagliflozin + Saxagliptin to revert from a standard basalbolus insulin treatment (BBIT) regimen to a basal supported oral therapy (BOT) in patients with Type 2 Diabetes – a randomis... 2020-02-03 due-trials
Not reported Terminated 2015-005817-61 iVAC-CLL01: Patient-individualized peptide vaccination after first line therapy of CLL 2022-07-25 due-trials
Other 2016-000222-19 Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome ¿ a blinded randomized placebo-controlled parallel group multicenter trial for superiority ... not-yet-due
Completed, but no date, and reported results Terminated 2016-003223-30 Prophylactic treatment of hemiplegic migraine with Lamotrigine Prophylaktische Therapie der hemiplegischen Migräne mit Lamotrigin bad-data
Reported results 2016-003477-18 A double-blind randomized study to determine the effect of empagliflozin versus placebo on brain insulin sensitivity in patients with prediabetes 2019-12-04 due-trials
Exempt 2016-003705-34 PIGMENT – PDE6A gene therapy for retinitis pigmentosa PIGMENT – PDE6A Gentherapie für Retinitis Pigmentosa not-yet-due
Reported results 2016-004505-13 Tocilizumab for the Treatment of Familial Mediterranean Fever – A randomized, doubleblind, phase II proof of concept study-TOFFIFE 2021-06-17 due-trials
Completed, but no date, and reported results Terminated 2016-004614-10 An open label phase II study to evaluate safety and efficacy of combined treatment with ipilimumab and nivolumab in patients with four and more symptomatic brain metastases of melanoma Eine offene ... bad-data
Reported results 2017-001355-31 Penumbral Rescue by Normobaric O=O Administration in Patients with Ischemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial Rescate de la zona de penumbra mediante la administ... 2022-08-22 due-trials
Not reported 2017-002588-17 Safety and effects on visual function of 0.01% Atropin eye drops for myopia inhibition in children and adolescents Sicherheit und Auswirkungen auf die Sehfunktion von 0,01% Atropin-Augentropfen zur... 2022-12-09 due-trials
Reported results 2017-002723-16 Evaluation of the potential anti-malarial effect of ivermectin: a controlled human malaria infection trial Evaluierung von Ivermectin als Wirkstoff gegen Malaria: eine kontrollierte Malariainfekti... 2018-12-12 due-trials
Ongoing 2017-003057-42 Organ preservation in locally advanced rectal cancer by radiochemotherapy followed by consolidation chemotherapy. A prospective phase II pilot trial of the German Rectal Cancer Study Group Organerh... not-yet-due
Completed, reported early Terminated 2017-003296-60 Empagliflozin effect on glucose toxicity in type 2 diabetes patients - a randomized, open-label, controlled, parallel group, exploratory study 2023-05-03 not-yet-due
Exempt 2017-003387-12 Dopamine action on metabolism depending on genetic heterogeneity – a randomized, placebo-controlled double blind study not-yet-due
Reported results Terminated 2017-004889-10 Dapagliflozin effect on erythropoiesis and physical fitness in patients with type 2 diabetes - a randomized, partly double-blinded, controlled, three armed, parallel group, exploratory study Einflu... 2021-11-30 due-trials
Ongoing 2018-000453-41 Effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcome of extremely preterm infants – a randomized controlled parallel group multicenter trial for safety an... not-yet-due
Reported results Terminated 2018-001433-41 Phase II Studie zur Verminderung der Peritonealkarzinose-Inzidenz nach kurativer Gastrektomie eines Magenkarzinoms oder Adenokarzinoms des gastroösophagealen Übergangs durch hypertherme intraperitonea... 2021-06-28 due-trials
Reported results Terminated 2018-003557-21 Effect of insulin glargine and lixisenatide versus insulin glargine on brain insulin sensitivity in patients with type 2 diabetes 2020-06-29 due-trials
Exempt, with results Terminated 2018-004523-36 Safety and protective efficacy of a simplified Plasmodium falciparum sporozoite Chemoprophylaxis Vaccine (PfSPZ-CVac) regimen in healthy malaria-naïve adults in Germany Sicherheit und Wirksamkeit ... 2021-08-16 not-yet-due
Ongoing 2019-001692-37 Pharmacologic treatment augmentation in chronic depression randomized, controlled, double blinded, phase II study not-yet-due
Not reported Terminated 2019-002607-18 Randomized, controlled interventional trial to investigate the efficacy of amiloride for the treatment of edema in human nephrotic syndrome Randomisierte, kontrollierte Interventionsstudie zur Unte... 2022-04-30 due-trials
Completed, but no date 2019-004946-13 Conversion to extended-release MeltDose® tacrolimus after kidney transplantation - impact on glucose metabolism and lipid profile bad-data
Reported results Terminated 2020-001224-33 Randomized controlled trial of hydroxychloroquine versus placebo for the treatment of adult patients with acute coronavirus disease 2019 – COVID-19 2021-02-26 due-trials
Reported results Terminated 2020-001482-37 Randomized controlled trial of hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of elderly COVID-19 Patients 2021-01-07 due-trials
Reported results Terminated 2020-001512-26 Hydroxychloroquine for the treatment of mild COVID-19 disease 2020-10-12 due-trials
Reported results 2020-002502-75 P-pVAC-SARS-CoV-2: Phase I single-center safety and immungenicity trial of multi-peptide vaccination to prevent COVID-19 infection in adults 2021-09-21 due-trials
Ongoing 2020-002622-87 A phase II trial of belimumab in combination with rituximab/venetoclax in patients with refractory or relapsed chronic lymphocytic leukemia not-yet-due
Completed, report not yet due 2021-001070-38 B-pVAC-SARS-CoV-2: Phase I/II multi-center safety and immungenicity trial of multi-peptide vaccination to prevent COVID-19 infection in adults with B-cell/antibody deficiency 2023-04-14 not-yet-due
Other 2021-004328-13 Early detection of side effects in patients with metastatic melanoma receiving immune checkpoint inhibitor therapy by investigation of the CD8+ immune infiltrate using [89Zr]Zr-Df-IAB22M2C-PET not-yet-due
Ongoing 2021-005721-25 SGLT2 inhibition in addition to lifestyle intervention and risk for complications in subtypes of patients with prediabetes - a randomized, placebo controlled, multi-center trial not-yet-due
Exempt 2022-000557-88 A Prospective Phase I/II, Single-Arm, Open-Label, Multicentre Study to Evaluate the Safety and Efficacy of Tafasitamab (MOR00208) in Pediatric Patients with Relapsed or Refractory Acute B Lineage Leuk... not-yet-due
Other 2022-001080-27 A multi-center phase I/II trial of memory T cell donor lymphocyte infusions after transplantation of CliniMACS TCRα/β and CD19 depleted stem cell grafts from haploidentical donors for hematopoietic ce... not-yet-due
Ongoing 2022-002418-18 AmaNtadine for NeuroenhancEment in acutE patients Study - A prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES) not-yet-due
No trial status on register 2022-002793-91 Prospective phase I/II trial of an individualized peptide vaccine in pediatric and AYA patients with metastasized fusion-driven sarcomas following standard treatment Vakzinierung mit patientenindiv... bad-data